Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Performance of a new hepatitis C assay on the Bayer ADVIA Centaur Immunoassay System.

Clinical laboratory - 1 Jan 2004

Denoyel Gérard, van Helden Josef, Bauer Richard, Preisel-Simmons Barbara

Abstract excerpt

Bayer HealthCare LLC, Diagnostics Division has developed a new third-generation assay for the detection of antibodies to hepatitis C (anti-HCV) in human serum and plasma on the ADVIA Centaur immunoassay system. This assay employs magnetic particle separation technology with direct chemiluminescence for optimal assay performance. The assay is fully automated, requires a sample volume of 10 microl and has a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoanalysis
Share to Blood Donors
Share to Hepatitis C Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoassay

Share to Immunomagnetic Separation

Share to Luminescent Measurements

Share to Reagent Kits, Diagnostic

Share to Serologic Tests

Source

Identifiers

PMID: 15000223

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Performance of a new hepatitis C assay on the Bayer ADVIA Centaur Immunoassay System.PMID 15000223Read ↗

Detection of HCV core antigen in human serum and plasma with an automated chemiluminescent immunoassay.Semantic proximity Read ↗

Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assaySemantic proximity Read ↗

Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay.Semantic proximity Read ↗

Comprehensive Evaluation of the Elecsys® HCV Duo Immunoassay for Active Hepatitis C Detection: Insights from the DEPCDUO StudySemantic proximity Read ↗

Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays.Semantic proximity Read ↗

Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis.Semantic proximity Read ↗

An improved Abbott ARCHITECT assay for the detection of hepatitis B virus surface antigen (HBsAg).Semantic proximity Read ↗

Diagnosis and monitoring of HCV infection using the cobas® HCV test for use on the cobas® 6800/8800 systems.Semantic proximity Read ↗

Comparative performance of two commercial sample-to-result systems for hepatitis C virus quantitation and genotyping.Semantic proximity Read ↗

Comparison of anti-HCV combined with HCVcAg (Elecsys HCV Duo immunoassay) and anti-HCV rapid test followed by HCV RNA analysis using qRT-PCR to identify active infection for treatment.Semantic proximity Read ↗

Performance of the COBAS® AmpliPrep/COBAS TaqMan® automated system for hepatitis C virus (HCV) quantification in a multi-center comparison.Semantic proximity Read ↗

Performance evaluation of the Aptima® HCV Quant Dx assay for hepatitis C virus (HCV) RNA detection and quantification in comparison to the Abbott RealTime HCV assay.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.